Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inotiv (NOTV)
NASDAQ:NOTV
Inotiv (NOTV) Stock Price & Analysis
324 Followers
NOTV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.61 - $11.42
Previous Close$2.24
Volume787.55K
Average Volume (3M)565.04K
Market Cap
$54.68M
Enterprise Value$464.29M
Total Cash (Recent Filing)$22.00M
Total Debt (Recent Filing)$428.52M
Price to Earnings (P/E)-1.7
Beta2.29
Next Earnings
Aug 15, 2024EPS Estimate
-$0.59Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.29
Shares Outstanding25,790,680
10 Day Avg. Volume843,820
30 Day Avg. Volume565,039
Standard Deviation0.36
R-Squared0.25
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)-0.39
Price to Sales (P/S)0.10
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.99
Enterprise Value/Gross Profit2.81
Enterprise Value/Ebitda10.55
Forecast
1Y Price Target
$5.25Price Target Upside147.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Inotiv News
Bulls Say, Bears Say
Bulls Say
Business OutlookManagement expects to transition NHP sales to contracted business, which should lead to improved predictability.
Earnings PotentialShares are valued attractively at 5x forward EV/EBITDA compared to peers at 14x, implying upside potential.
Financial PerformanceFQ1’24 revenue of $135.5M was above consensus at $132.9M, indicating a top-line outperformance.
Bears Say
Company GuidanceManagement's fiscal year outlook for RMS is below analyst estimates, reflecting a cautious stance on non-human primate (NHP) pricing.
Financial PerformanceThe RMS segment contributed $90M, marking a decrease of 15% year-over-year.
Order BookingsA higher rate of cancellations has led to a decline in the book-to-bill ratio to 0.65x.
---
Ownership Overview
27.73% Insiders
9.67% Mutual Funds
11.08% Other Institutional Investors
51.51% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NOTV FAQ
What was Inotiv’s price range in the past 12 months?
Inotiv lowest stock price was $1.61 and its highest was $11.42 in the past 12 months.
What is Inotiv’s market cap?
Currently, no data Available
When is Inotiv’s upcoming earnings report date?
Inotiv’s upcoming earnings report date is Aug 15, 2024 which is in 91 days.
How were Inotiv’s earnings last quarter?
Inotiv released its earnings results on May 15, 2024. The company reported -$1.86 earnings per share for the quarter, missing the consensus estimate of -$0.384 by -$1.476.
Is Inotiv overvalued?
According to Wall Street analysts Inotiv’s price is currently Undervalued.
Does Inotiv pay dividends?
Inotiv does not currently pay dividends.
What is Inotiv’s EPS estimate?
Inotiv’s EPS estimate is -$0.59.
How many shares outstanding does Inotiv have?
Inotiv has 25,790,680 shares outstanding.
What happened to Inotiv’s price movement after its last earnings report?
Inotiv reported an EPS of -$1.86 in its last earnings report, missing expectations of -$0.384. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Inotiv?
Among the largest hedge funds holding Inotiv’s share is Royce & Associates LLC. It holds Inotiv’s shares valued at 555K.
---
Inotiv Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.25 (147.64% Upside)
$5.25 (147.64% Upside)
Blogger Sentiment
Bullish
NOTV Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 50.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.4%
Last 30 Days ▼ 9.7%
Last 30 Days ▼ 9.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.04%
12-Months-Change
Fundamentals
Return on Equity
-12.41%
Trailing 12-Months
Asset Growth
-4.08%
Trailing 12-Months
Company Description
Inotiv
Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
---
NOTV Earnings Call
Q2 2024
0:00 / 0:00
---
NOTV Stock 12 Month Forecast
Average Price Target
$5.25
▲(147.64% Upside)
Technical Analysis
Aptose Biosciences
―
Context Therapeutics
―
Enveric Biosciences
―
West Pharmaceutical Services
―
Best Analysts Covering NOTV
1 Year
1 Year Success Rate
2/11 ratings generated profit
1 Year Average Return
-35.69%
reiterated a buy rating 19 hours ago
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 18.18% of your transactions generating a profit, with an average return of -35.69% per trade.
---